Technological or institutional change has proven to be big cause for failure of established firms and history is full of such examples. The stregnhthening of patent laws as a result of TRIPs (Trade Related intellectual property rights) agreement represents such a institutional change for knowledge based industries from developing countries. This represents a radical break with the past in which developing countries typically had only weak levels of patent protection. In this context this research examined the learning processes involved in development of innovative capabilities in the Indian pharmaceutical firms as a response to strengthening of patent law. This research shows that Indian pharmaceutical firms are responding to disruptive re...
With the advent of gloablisation, the pace of social, economic, and regulatory transformations appea...
With increasing globalization, firms in emerging countries are facing turbulent business environment...
This paper analyzes the post-TRIPs behavior of domestic and foreign pharmaceutical firms in India in...
Technological or institutional change has proven to be a major cause of the failure of established f...
The intellectual property regime forms an important part of any government's economic and industrial...
The transition to a new technology, market or regulatory regime can be difficult for any organisatio...
Trade liberalisation and changes in the Intellectual Property Rights (IPR) have fashioned new dynami...
Over the last decade the Indian pharmaceutical industry has emerged as a leading supplier of generic...
ABSTRACT Firms face a difficult challenge to manage transition to new technologies,markets and regul...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...
Presented at the GLOBELICS 2006 conference in India during 4-7 October 2006.Session II-5 New IPR Reg...
321-329India, being a signatory of WTO agreements, has moved from no or partial patent protection to...
The Indian pharmaceutical industry represents a successful case of indigenous self-reliant developme...
301-317The full scale compliance of TRIPS Agreement essentially represents a big step in the oppos...
With the advent of gloablisation, the pace of social, economic, and regulatory transformations appea...
With increasing globalization, firms in emerging countries are facing turbulent business environment...
This paper analyzes the post-TRIPs behavior of domestic and foreign pharmaceutical firms in India in...
Technological or institutional change has proven to be a major cause of the failure of established f...
The intellectual property regime forms an important part of any government's economic and industrial...
The transition to a new technology, market or regulatory regime can be difficult for any organisatio...
Trade liberalisation and changes in the Intellectual Property Rights (IPR) have fashioned new dynami...
Over the last decade the Indian pharmaceutical industry has emerged as a leading supplier of generic...
ABSTRACT Firms face a difficult challenge to manage transition to new technologies,markets and regul...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...
This article demonstrates that radical regulatory changes can be tantamount to technological revolut...
Presented at the GLOBELICS 2006 conference in India during 4-7 October 2006.Session II-5 New IPR Reg...
321-329India, being a signatory of WTO agreements, has moved from no or partial patent protection to...
The Indian pharmaceutical industry represents a successful case of indigenous self-reliant developme...
301-317The full scale compliance of TRIPS Agreement essentially represents a big step in the oppos...
With the advent of gloablisation, the pace of social, economic, and regulatory transformations appea...
With increasing globalization, firms in emerging countries are facing turbulent business environment...
This paper analyzes the post-TRIPs behavior of domestic and foreign pharmaceutical firms in India in...